to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Traditional banks often don't know what to do with a business with no revenue and no developed product or service. But since bank financing is important for startups, it's a good idea to find a bank that understands startups' assets and the ebb and flow of startup sales and revenue cycles.
STC Biologics is a Cambridge-based biotechnology company focused on the development of biologic drugs. Magdalena Leszczyniecka, the company’s president and CEO, launched the business just as the market crashed. After several years in the field, Leszczyniecka shared her experiences with bartering, negotiating, and asking for help.
Join the conversation and find out what this week's eMed's 6 entrepreneurs to follow are saying.
Looking for early-stage financing for your life science or digital health startup? Crowdfunding, in which individuals and teams can raise money over the Internet from dozens or thousands of sources in small amounts, has become a popular financing tool.
Lisa Earnhardt, president and CEO of Intersect ENT, shares tips on finding your customer, working with physicians, and collaborating with the FDA.
Because significant funding is needed to develop new, innovative life science and digital health products and tools, fewer ideas are making the leap from research institutions to product development teams. This clash between the short-term, earnings-driven needs of the medical marketplace and the risky, lengthy, and capital-intensive process of bringing medical ideas to fruition is a major challenge facing modern medicine.
"Med tech is alive and well, despite what we hear out there," Kevin Wasserstein, founder and principal at MentorCatalyst, told the attendees of today’s MedTech Investing Conference.
Dinu Sen, CEO of Amplyx Pharmaceuticals, offers tips on finding need in the sector, hiring, and determining whether working with an accelerator is right for your company.
Medical technology innovators and investors from across the country will gather Wednesday in Minneapolis for the 12th annual MedTech Investing Conference. With panels on alternative funding models, maximizing ROI, and the FDA on the agenda, we asked conference co-chair Dennis Wahr, CEO of Holaira, what insights life science and digital health entrepreneurs can expect to take away from the event.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
